Quick Takeaways
- INTRACOASTAL CAPITAL, LLC filed SCHEDULE 13G for Cellectar Biosciences, Inc. Common stock, par value $0.00001 per share (CLRB).
- Disclosed ownership: 5%.
- Date of event: 01 Jul 2025.
INTRACOASTAL CAPITAL, LLC - 01 Jul 2025 SCHEDULE 13G Report for Cellectar Biosciences, Inc. Common stock, par value $0.00001 per share (CLRB)
- Filing Manager
- INTRACOASTAL CAPITAL, LLC
- Reporting Manager
- Mitchell P. Kopin
- Symbol
- CLRB
- Shares outstanding
- 2,807,635 shares
- Disclosed Ownership
- 140,101 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Jul 2025, 17:02:22 UTC
- Date of event
- 01 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTRACOASTAL CAPITAL, LLC disclosed 5% ownership in Cellectar Biosciences, Inc. Common stock, par value $0.00001 per share (CLRB) on 01 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jul 2025, 17:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mitchell P. Kopin | 5% | 140,101 | 0 | 140,101 | /s/ Mitchell P. Kopin | Mitchell P. Kopin | |
| Daniel B. Asher | 5% | 140,101 | 0 | 140,101 | /s/ Daniel B. Asher | Daniel B. Asher | |
| Intracoastal Capital LLC | 5% | 140,101 | 0 | 140,101 | /s/ Mitchell P. Kopin | Mitchell P. Kopin, Manager |